Aspartame

CAS No. 22839-47-0

Aspartame ( L-Aspartyl-L-Phenylalanine methyl ester )

Catalog No. M13628 CAS No. 22839-47-0

Aspartame is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 In Stock
1G 56 In Stock

Biological Information

  • Product Name
    Aspartame
  • Note
    Research use only, not for human use.
  • Brief Description
    Aspartame is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages.
  • Description
    Aspartame is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages.
  • Synonyms
    L-Aspartyl-L-Phenylalanine methyl ester
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Taste receptor; Transient receptor potential cation channel
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    22839-47-0
  • Formula Weight
    294.30
  • Molecular Formula
    C14H18N2O5
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 4 mg/mL (13.59 mM); DMSO: 33 mg/mL (112.13 mM)
  • SMILES
    O=C(O)C[C@H](N)C(N[C@@H](CC1=CC=CC=C1)C(OC)=O)=O
  • Chemical Name
    (3S)-3-Amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Xu H, et al. Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14258-63.
molnova catalog
related products
  • EVP-6124 hydrochlori...

    EVP-6124 hydrochloride is a new-type partial agonist of α7 neuronal nicotinic acetylcholine receptors (nAChRs).

  • RS 17053 hydrochlori...

    RS 17053 hydrochloride is an effective and selective antagonist of α1A-adrenergic receptor with pA2 of 9.8 in functional assays and pKi of 9.1 in the native cell membrane.

  • Braco-19 trihydrochl...

    BRACO19 is a telomerase inhibitor. It also stabilizes G-quadruplexes, targeting telomeric G-quadruplexes.